期刊文献+

厄贝沙坦联合氢氯噻嗪治疗原发性高血压疗效观察 被引量:1

下载PDF
导出
摘要 目的观察厄贝沙坦联合氢氯噻嗪治疗原发性高血压的疗效及安全性。方法将56例1-2级原发性高血压患者随机分为2组,治疗组口服厄贝沙坦150 mg/d及氢氯噻嗪12.5 mg/d,对照组仅服厄贝沙坦150 mg/d,2组疗程均为8周。在治疗第1,2,4,8周末记录血压、心率及不良反应。结果治疗组总有效率93%,对照组总有效率79%,2组比较有显著性差异(P<0.01)。结论厄贝沙坦和氢氯噻嗪联用能有效控制血压,用药简单、方便,不良反应少,是值得临床推广的联合降压方案。
作者 蔡文花
出处 《现代中西医结合杂志》 CAS 2007年第28期4138-4138,4198,共2页 Modern Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献4

二级参考文献27

  • 1[10]NAKASHIMA M, UMEMURA K. The clinical pharmacology of losartan in Japanese subjects and patients[J]. Blood Press Suppl,1996,2:62-66.
  • 2[11]SONG JC, WHITE CM. Pharmacologic, pharmacokinetic, and therapeutics differences among angiotensin Ⅱreceptor antagonists [J]. Pharmacotherapy, 2000,20(2):130-139.
  • 3[12]NEUTEL JM, KLEIN C, MEINICKE TW, et al. Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications[J].Blood Press,2002,11(5):302-309.
  • 4[13]PRASAD PP, YEH CM, GURRIERI P, et al. Pharmacokinetics of multiple doses of valsartan in patients with heart failure[J]. J Cardiovasc Pharmacol,2002,40(5):801-807.
  • 5[14]SMITH DH, MATZEK KM, KEMPTHORNE-RAWSOWL J. Dose response and safety of telmisartan in patients with mild to moderate hypertension[J]. J Clin Pharmacol,2000,40(12 Pt 1):1380-1390.
  • 6[15]SASAKI M, FUJIMURA A, HARADA K, et al. Clinical pharmacology of multiple-dose losartan an angiotensin Ⅱ receptor antagonist, in patients with essential hypertension[J]. J Clin Pharmacol, 1996, 36(5):403-408.
  • 7[16]RUILOPE L. Human pharmacokinetic/pharmacodynemic profile of irbesartan: a new potent angiotensin Ⅱ receptor antagonist[J]. J Hypertens Suppl,1997 ,15 (7):S15-S20.
  • 8[17]McCLELLAN KJ, GOA KL. Candesartan cilexetil. A review of its use in essential hypertension[J]. Drugs,1998,56(5):847-869.
  • 9[18]PHILIPP T, LETZEL H, ARENS HJ. Dose-finding study of candesartan cilexetil plus hydrochlorothiazide in patients with mild to moderate hypertension[J]. J Hum Hypertens,1997 ,11 Suppl 2:S67-S68.
  • 10[19]McGILL JB, REILLY PA. Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized ,double-blind, placebo-controlled, parallel-group trial [J]. Clin Ther,2001, 23(6):833-850.

共引文献58

同被引文献4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部